MusclePharm Corporation Convertible Debt, Current
MusclePharm Corporation had Convertible Debt, Current of $5.33 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2022-05-16
- 2022-03-31: Convertible Debt, Current $5.33M.
- 2021-12-31: Convertible Debt, Current $5.33M.
- 2021-09-30: Convertible Debt, Current $5.33M.
- 2021-06-30: Convertible Debt, Current $2.87M.
| Period end | Convertible Debt, Current |
|---|---|
| 2022-03-31 | $5.33M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.33M 10-Q · filed 2022-05-16 |
| 2021-09-30 | $5.33M 10-Q · filed 2021-11-17 |
| 2021-06-30 | $2.87M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.87M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $2.87M 10-K/A · filed 2022-05-04 |
| 2020-09-30 | $2.73M 10-Q · filed 2020-11-24 |
| 2020-06-30 | $1.03M 10-Q · filed 2020-11-24 |
| 2020-03-31 | $1.03M 10-Q · filed 2020-11-24 |
| 2019-12-31 | $1.29M 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.16M 10-Q · filed 2020-08-25 |
| 2019-06-30 | $17.97M 10-Q · filed 2020-08-25 |
| 2019-03-31 | $17.95M 10-Q · filed 2020-08-25 |
| 2018-12-31 | $17.94M 10-Q · filed 2020-08-25 |